Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07132515

Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC

We will give an anticoagulant against portal vein thrombosis, and watch for the results.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Cirrhosis Adenocarcinoma Carcinoma Carcinoma, Hepatocellular Digestive System Diseases Digestive System Neoplasms Fibrosis HCC - Hepatocellular Carcinoma Liver Diseases Liver Neoplasms Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Glandular and Epithelial Pathologic Processes Pathological Conditions, Signs and Symptoms Portal Vein Thrombosis

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Mansoura University Hospitals

Al Mansurah, Dakahlia Governorate, 35511, Egypt

Location status: Recruiting

Location contact

Dalia E Tawfik

CONTACT

[email protected]

+20 1095529264

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Portal vein thrombosis, Cirrhosis, With or without HCC, Child A & B

Exclusion criteria

  • Platelets<10000, Createnine >1.9, Budd ciarri, Uncontrolled active bleeding

Treatment and study plan

Enoxaparin, warfarrin, or apixaban

Drug

Enoxaparin, warfarrin, or apixaban

Primary outcomes

  1. Portal vein thrombosis

    Time frame: 6 months

    determine if thrombus resolved or not on anticcoagulant by triphasic CT

Study contacts

Contact information is provided by the study sponsor or research team.

Dalia Elsayed Ganady, MBBS

CONTACT

[email protected]

+201095529264

Hatem Elalfy, PhD

CONTACT

[email protected]

+201224790518

Sponsors and collaborators

Lead sponsor

Mansoura University

Other

Registry information

Official study title

Efficacy and Safety of Anticoagulant Therapy for Portal Vein Thrombosis In Cirrhosis Patients With and Without Hepatocellular Carcinoma

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Aug 20, 2025
Registry last updated
Aug 20, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.